We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RSE
1901
DELISTED
ROUSE PPTYS INC COM (DE)
RSE
| $933K | ﹤0.01% |
49,189
+1,200
| +3% | +$22.5K |
|
|
FFG
1902
DELISTED
FBL Financial Group
FFG
| $929K | ﹤0.01% |
14,985
+700
| +5% | +$39.7K |
|
|
RRTS
1903
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $929K | ﹤0.01% |
1,470
+92
| +7% | +$55.2K |
|
|
CEMP
1904
DELISTED
Cempra, Inc.
CEMP
| $927K | ﹤0.01% |
27,025
+11,100
| +70% | +$334K |
|
1905
MiMedx Group
MDXG
$633M
| $924K | ﹤0.01% |
88,868
+14,175
| +19% | +$133K |
|
1906
National Bank Holdings
NBHC
$1.9B
| $924K | ﹤0.01% |
49,146
-5,375
| -10% | -$99.7K |
|
|
ZINC
1907
DELISTED
HORSEHEAD HLDG CORP COM STK (DE)
ZINC
| $924K | ﹤0.01% |
72,955
+5,350
| +8% | +$72.8K |
|
|
AVTA
1908
DELISTED
Avantax, Inc. Common Stock
AVTA
| $923K | ﹤0.01% |
67,562
+400
| +0.6% | +$5.58K |
|
|
CPLA
1909
DELISTED
Capella Education Company
CPLA
| $923K | ﹤0.01% |
14,232
+1,775
| +14% | +$120K |
|
|
BBT
1910
Beacon Financial Corp
BBT
$2.66B
| $921K | ﹤0.01% |
33,263
+1,200
| +4% | +$31.4K |
|
|
RPXC
1911
DELISTED
RPX Corporation
RPXC
| $921K | ﹤0.01% |
64,017
+1,900
| +3% | +$26.1K |
|
1912
Gibraltar Industries
ROCK
$1.49B
| $920K | ﹤0.01% |
56,074
+1,700
| +3% | +$26.3K |
|
|
MFRM
1913
DELISTED
MATTRESS FIRM HLDG CORP COM STK (DE)
MFRM
| $919K | ﹤0.01% |
13,202
+2,100
| +19% | +$129K |
|
1914
Artisan Partners
APAM
$3.02B
| $918K | ﹤0.01% |
20,200
+490
| +2% | +$23.2K |
|
|
ACET
1915
DELISTED
Aceto Corp
ACET
| $917K | ﹤0.01% |
41,688
+1,800
| +5% | +$37.7K |
|
1916
World Acceptance Corp
WRLD
$872M
| $915K | ﹤0.01% |
12,554
+1,050
| +9% | +$84.7K |
|
|
NEWP
1917
DELISTED
NEWPORT CORP
NEWP
| $915K | ﹤0.01% |
48,005
+4,450
| +10% | +$86.1K |
|
1918
M/I Homes
MHO
$3.84B
| $914K | ﹤0.01% |
38,358
-1,180
| -3% | -$25.8K |
|
|
DCOM
1919
DELISTED
Dime Community Bancshares
DCOM
| $914K | ﹤0.01% |
56,780
+1,400
| +3% | +$21.8K |
|
1920
Tredegar Corp
TG
$310M
| $912K | ﹤0.01% |
45,343
+1,250
| +3% | +$26.2K |
|
|
TTPH
1921
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $911K | ﹤0.01% |
1,243
+239
| +24% | +$180K |
|
1922
UBS Group
UBS
$176B
| $906K | ﹤0.01% |
+48,252
| New | +$840K |
|
1923
QuidelOrtho
QDEL
$838M
| $904K | ﹤0.01% |
33,499
+4,100
| +14% | +$105K |
|
1924
Alaunos Therapeutics
TCRT
$4.86M
| $898K | ﹤0.01% |
556
+111
| +25% | +$165K |
|
|
MNR
1925
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $898K | ﹤0.01% |
80,794
+4,300
| +6% | +$49.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.